BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 16307811)

  • 1. Polymer conjugates: nanosized medicines for treating cancer.
    Vicent MJ; Duncan R
    Trends Biotechnol; 2006 Jan; 24(1):39-47. PubMed ID: 16307811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer conjugates as anticancer nanomedicines.
    Duncan R
    Nat Rev Cancer; 2006 Sep; 6(9):688-701. PubMed ID: 16900224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
    Duncan R; Vicent MJ; Greco F; Nicholson RI
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S189-99. PubMed ID: 16113096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dawning era of polymer therapeutics.
    Duncan R
    Nat Rev Drug Discov; 2003 May; 2(5):347-60. PubMed ID: 12750738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
    Greco F; Vicent MJ
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG conjugates in clinical development or use as anticancer agents: an overview.
    Pasut G; Veronese FM
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1177-88. PubMed ID: 19671438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics.
    Gaspar R; Duncan R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1220-31. PubMed ID: 19682513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer therapeutics: concepts and applications.
    Haag R; Kratz F
    Angew Chem Int Ed Engl; 2006 Feb; 45(8):1198-215. PubMed ID: 16444775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
    Lukyanov AN; Torchilin VP
    Adv Drug Deliv Rev; 2004 May; 56(9):1273-89. PubMed ID: 15109769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable amphiphilic polymer-drug conjugate micelles.
    Hu X; Jing X
    Expert Opin Drug Deliv; 2009 Oct; 6(10):1079-90. PubMed ID: 19645633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-drug conjugates: current status and future trends.
    Greco F; Vicent MJ
    Front Biosci; 2008 Jan; 13():2744-56. PubMed ID: 17981750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-drug conjugates as modulators of cellular apoptosis.
    Vicent MJ
    AAPS J; 2007 Jun; 9(2):E200-7. PubMed ID: 17907762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and development of polymer conjugates as anti-angiogenic agents.
    Segal E; Satchi-Fainaro R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1159-76. PubMed ID: 19699248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New possibilities of application of multifunctional polymers and polymer conjugates.
    Pluta J; Karolewicz B
    Acta Pol Pharm; 2003; 60(3):211-4. PubMed ID: 14556491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
    Taurin S; Nehoff H; Greish K
    J Control Release; 2012 Dec; 164(3):265-75. PubMed ID: 22800576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.